1-3 of 3
B. Lowenberg, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Multicentre Phase II Study of the Aminopeptidase Inhibitor, CHR- 2797, in the Treatment of Elderly and/or Previously Treated patients with Acute Myeloid Leukemia.

B. Lowenberg, MD, F. Davies, MD, C. Müller-Tidow, MD, Ulrich Dührsen, A. Burnett, MD, FRCP, P. Zachée, MD, PhD, D. Dierickx, MD, C. Jenkins, MD, P. Sonneveld, MD, M. Jongen-Lavrencic, MD, S. Zweegman, MD, G. Morgan, MD, U. Krug, MD, A. Richardson, PhD, L. Hooftman, MD, G. Ossenkoppele, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 961.
https://doi.org/10.1182/blood.V112.11.961.961
Published: 2008
Journal Articles

Mutant Wilms’ Tumor 1 ( WT1 ) mRNA with Premature Termination Codons Is Sensitive to Nonsense-Mediated RNA Decay in Acute Myeloid Leukemia (AML)

Saman Abbas, Claudia Erpelinck, Chantal Goudswaard, B. Lowenberg, MD, Peter Valk, PhD
Journal: Blood
Blood (2008) 112 (11): 2538.
https://doi.org/10.1182/blood.V112.11.2538.2538
Published: 2008
Journal Articles

Gene Expression Profiles with Signatures of Tumor Biology and Chemotherapy Sensitivity May Provide a Novel Approach to Maximize Response to Induction Therapy in Patients with Acute Myeloid Leukemia.

Arati V Rao, Sascha A Tuchman, Anil Potti, David A. Rizzieri, MD, Hiroyuki Mano, Ruud Delwel, PhD, Peter Valk, B. Lowenberg, MD
Journal: Blood
Blood (2008) 112 (11): 2252.
https://doi.org/10.1182/blood.V112.11.2252.2252
Published: 2008